Moberg Pharma AB reported strong interest from pharmacists, physicians and end customers in the launch of MOB-015 under the brand Terclara® in Sweden. A majority of Swedish pharmacies now have the product available on the shelf. Interest in the product exceeds the pharmacy chains' forecasts, and chains are increasing their orders due to that Terclara® has occasionally sold out at several of the pharmacy chains. However, there is a well-stocked wholesale warehouse. Patients are also verifying the great need for new treatment options for nail fungus and are receiving patient inquiries from many countries, as Sweden is the first country where the drug is being launched.
Terclara® has been available on Swedish pharmacy shelves since February this year. In parallel with the pharmacies filling up the shelves, work was ongoing in February and March to inform physicians and pharmacists about the unique benefits of Terclara®. Now, the focus is shifting to end consumers, with TV marketing started on April 1st as planned.